全腹腔外內視鏡疝氣手術使用自製改良的surgipro網膜之經驗
闕光瞬、李經家
高雄市立大同醫院 泌尿科
An experience with self-maid modified Surgipro mesh for laparoscopic total extraperitoneal herniorrhaphy
Kuang-Shun Chueh, Ching-Chia Li
Department of Urology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan
Purpose: This is a review of the efficacy and safety by using a modified Surgipro mesh repair when performing laparoscopic total extraperitoneal herniorrhaphy.
Materials and Methods: We retrospectively reviewed patients who underwent laparoscopic total extraperitoneal herniorrhaphy in a single constitution from February 22th, 2012 to March 8th, 2016. A total 92 patients received modified Surgipro mesh laparoscopic total extraperitoneal herniorrhaphy. Postoperative results with recurrence, epididymo-orchitis, and other major complications were recorded and analyzed.
Results: A total of 92 patients underwent laparoscopic total extraperitoneal herniorrhaphy with modified Surgipro mesh. Of all, 31 patients were bilateral inguinal hernia, 15 patients were recurrent inguinal hernia and 17 patients were bilateral, recurrent (single or both side) inguinal hernia. Mean total operative time (skin to skin) was 107 minutes. No patient had recurrent hernia. One patient had major bleed and recovered after emergent laparotomy. One patient had scrotal hematoma and received surgical removal. Five patients experienced epididymo-orchitis and needed antibiotic treatment for one more week.
Conclusions: With modified Surgipro mesh, laparoscopic total extraperitoneal herniorrhaphy is efficacy and safe. Longer follow-up and larger study group are still necessary.